 Provider News OhioNovember 1, 2024 November 2024 Provider Newsletter Featured Articles Quality Management | Commercial / Medicare Advantage / Medicaid Managed Care | October 25, 2024 Education & Training | Medicaid Managed Care | October 23, 2024 Administrative | Commercial | October 23, 2024 Administrative | Medicaid Managed Care | October 23, 2024 Digital Solutions | Commercial | October 21, 2024 Education & Training | Medicare Advantage | October 15, 2024 Administrative | Medicaid Managed Care | September 1, 2024
OHBCBS-CDCRCM-070465-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). The Department of Health & Human Services (HHS) requires health plans to report whether or not our in-network providers offer telehealth services. If you provide telehealth services, please tell us by submitting your information to us through Availity.com. Updating your telehealth status will not affect your participation with us. We will add a telehealth indicator to your online provider directory profile, allowing our members to know you offer telehealth services. If you have questions about submitting your information, please see the instructions below. If your organization is not currently registered with Availity, you will need to create an account. The person(s) designated as your administrator(s) should go to Availity.com and select Get Started in the upper right corner of the webpage. You may also navigate directly to Availity’s registration website by selecting here. Begin your application here. To update your application: - Log in to Availity Essentials.
- Select My Providers.
- Select Provider Data Management.
Please update your telehealth information at the service location. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069888-24-CPN69222 In today's rapidly evolving healthcare landscape, the accuracy of provider data is a critical component of ensuring operational efficiency, regulatory compliance, and overall patient satisfaction. A recent survey suggests there is opportunity for providers to correct their data with us. Ohio Medicaid Managed Care providers maintain their data on Ohio’s Provider Network Management (PNM) module. Providers should ensure that all data is correct, paying particular attention to addresses, phone numbers, and office hours. Accurate data in the PNM in critical so that your patients — our members — can reach you and access the services they need. To learn more about the PNM module and centralized credentialing, visit PNM & Centralized Credentialing (ohio.gov). If you have questions, send an email to ohiomedicaidprovider@anthem.com. You may also locate your dedicated provider relationship account associate on the territory map. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-071196-24 Note: This communication does not apply to outpatient hospital services. Providers who administer vaccines to children through 18 years of age should enroll in the Immunizations Covered by Vaccines for Children (VFC) program. We will reimburse only the administration fee for any vaccine available through the VFC program. When submitting claims for vaccines and/or toxoids covered under the VFC program: - Providers should bill CPT® 90460 for the administration.
- When administering more than one vaccine, providers should bill the number of vaccines as units:
- For example, if two vaccines are administered, the claim should be billed with an E/M code, two individual vaccines and/or toxoids, and two units of 90460.
- We do not require the SL modifier to be appended.
If you have questions regarding Vaccines for Children, visit the following: Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-070107-24 Beginning with claims processing on or after December 1, 2024, we will update our outpatient facility claims editing process to deny claim lines when an add-on code is reported without a primary procedure code. An add-on code is a specific type designated by the HCPCS or CPT®. These codes describe additional procedures or services performed with a primary procedure. According to CPT guidelines, add-on codes must be reported with a primary procedure code. If you believe you have received a claim denial in error, please follow our claim dispute process. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070181-24-CPN69226 
What are three things everyone should know about you?I was born and raised in Cincinnati, Ohio. I am a single father now raising three amazing children of my own — one boy and two girls. I have always held big dreams and look forward to living on top of a mountain coastline one day. I enjoy broadening my children’s perspective on life and taking them to enjoy new places and learning unique facts about the world. I am a creative type. In my personal time I enjoy writing music and designing sound for independent projects in the film, television, and game space. I am a self-taught pianist with an inclination toward classical styles. I have a passion for all types of music and consider myself eclectic in music I enjoy and music I create. Following my dreams, I have earned a bachelor’s degree in music production and a master’s degree in business. I have utilized my passion to open a home production studio where I discover new talent, manage artists, produce, and license music for use in a variety of projects. While I chased a passion for music, I do enjoy following my heart for creative writing with poetry and short stories being among my favorites. As weird as it may sound, I also have a love for technical, business, and legal writing. What is one thing you never leave home without?My Frisbees! I always keep a backpack full of disc golf gear in my trunk in case I want to stop at a park and throw a few holes. Who has been the most influential in your life?I have found in life that the deepest and most impactful influences on me have come from people’s stories. Tell me your story, and I am certain to find both wisdom and inspiration. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-066947-24 In July, we announced an enhancement to the 277CA to notify you of submission errors discovered during claims processing.
As of November 1, 2024, the 277CA will include additional corrective action types for your review. As communicated in July, these errors will still be sent through physical mailing.
With these added error types, there is no reduction to the services we already provide.
Through our efforts, we are committed to reducing administrative burden, improving communication, and ensuring timely payments because we value you, our care provider partners.
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069544-24-CPN69313 There are new resources available for providers to complete the Pregnancy Risk Assessment Form electronically, or ePRAF (Electronic Pregnancy Risk Assessment Form). To access this form, log in to the NurtureOhio website where you will find information on how to use the ePRAF. Quality Enhancer Incentive Program for ePRAF The Quality Enhancer Incentive Program provides increased payments to eligible providers who submit the ePRAF via the NurtureOhio website on behalf of their pregnant patients. Technical Assistance Intervention Package for ePRAF The Technical Assistance Intervention Package is a collection of resources, tools, and reporting that is designed to assist Providers in delivering high-quality pregnancy related care to their patients. For more information on using the ePRAF, please contact us at ohiomedicaidprovider@anthem.com. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-048680-23, OHBCBS-CD-049383-24-SRS48922, OHBCBS-CD-049390-24-SRS48922, OHBCBS-CD-049393-24-SRS48922, OHBCBS-CD-049391-24-SRS48922, OHBCBS-CD-049392-24-SRS48922, OHBCBS-CD-048922-24-SRS48922, OHBCBS-CD-049387-24-SRS48922, OHBCBS-CD-049384-24-SRS48922, OHBCBS-CD-049388-24-SRS48922, OHBCBS-CD-049389-24-SRS48922, OHBCBS-CD-049385-24-SRS48922 This article was updated as of October 15, 2024. This guidance concerns: - Claims payment disputes versus claims payment appeals
- Clinical appeals for adverse utilization management (UM) decisions.
Claims payment disputes versus claim payment appealsQ: What is a claims payment dispute? A: A claims payment dispute is the provider’s initial request for a review into the outcome of a claim once it is finalized. Q: What is a claims payment appeal? A: If a provider disagrees with the outcome of the claims payment dispute, the provider may request a second-level review, known as a claim payment appeal. Q: When should providers file a claim payment dispute or claim payment appeal? A: Claims payment disputes and claim payment appeals can be filed when claims are underpaid, overpaid, denied for no authorization (additional information below), or payment was denied for any reason other than medical necessity. Review our provider manual (PDF) for additional reasons a claim payment dispute or appeal may be filed. We accept both claims payment disputes and appeal requests within 365 days from the date of service (DOS) or 60 calendar days from the date on the Explanation of Payment (EOP), whichever is later. Q: How can providers file a claims payment dispute and claim payment appeal? A: Both the claims payment dispute and claim payment appeal can be filed via the preferred method of Availity Essentials or by mail or phone; call Provider Service at 844-912-1226. The mailing address can be found in our provider manual (PDF). Q: What documentation is required when filing a claims payment dispute or a claim payment appeal? A: - Your name, address, phone number, email, and either your National Provider Identifier or tax ID
- The member’s name and their Anthem or Medicaid ID number
- A listing of disputed claims, which should include the claim number and the date(s) of service(s)
- All supporting statements and documentation
- A detailed explanation of the reason for the appeal
Note: We cannot process a claim payment appeal without a claims payment dispute on file. Clinical appeals for adverse utilization management (UM) decisionsQ: When should providers file a clinical reconsideration? A: The clinical reconsideration process is available to providers following an adverse medical determination within 30 days from the initial denial and when there is new clinical information or information that was not already provided in the initial review. Q: How do providers file a clinical reconsideration? A: - Physical health: Fax to 877-643-0671
- Behavioral health: Fax to 866-577-2184
Q: What is needed to file a clinical reconsideration? A: During the clinical reconsideration process, providers have an opportunity to submit additional clinical information to substantiate medical necessity for a previously denied preservice or concurrent inpatient stay. Providers should also include reconsideration on the cover sheet if submitting via fax. Q: When can providers request a peer-to-peer consultation? A: Providers who disagree with an adverse medical necessity decision can request a peer-to-peer by contacting Anthem within seven calendar days of the initial determination or seven days after the determination of clinical reconsideration. To request a peer-to-peer, call Provider Services: - Behavioral health: 844-441-1506
- Physical health: 833-308-3035
When you request a peer-to-peer review, Anthem will acknowledge your request within 24 hours and offer a peer-to-peer conversation within a mutually agreed-upon time. Q: When can providers file a preservice clinical appeal? A: If an authorization is denied prior to the service being rendered to the member, the provider has the option to file a pre-service clinical appeal directly with Anthem and can do so without the member’s consent. If filing without the member’s consent, appeals must be submitted within 30 calendar days of the initial determination. If filing on behalf of a member, providers have 60 calendar days from the initial determination to submit their preservice clinical appeal, along with the member’s consent. Additional information can be found in our Provider Manual (PDF). Q: How do providers file a preservice clinical appeal? A: Q: If a provider fails to request a prior authorization (PA) can the service be reviewed retrospectively? A: Yes, providers who fail to obtain a PA can request that services already administered be reviewed for medical necessity via a claim payment dispute. The dispute should be submitted after the claim denies for no authorization. Upon receipt of the claim payment dispute, Anthem will review the service retrospectively for medical necessity. When submitting a claim payment dispute, the provider must submit medical documentation and provide the extenuating circumstances for not submitting the PA. Claim payment disputes are to be submitted within 365 days from the DOS or 60 calendar days from the date on the Explanation of Payment, whichever was later. Q: How do providers file postservice clinical appeals? If there is an adverse determination of medical necessity, a post-service clinical appeal can be submitted (guidance above). Q: When can providers file an external medical review (EMR)? A: Providers who have exhausted appeal rights can request an EMR within 30 calendar days of Anthem’s decision to deny, limit, reduce, suspend, or terminate a covered service for lack of medical necessity. The EMR is available at no cost to providers. The request for EMR must be submitted to Permedion (gainwelltechnologies.com) within 30 calendar days of the written notification that the internal appeals process has been exhausted. Providers must complete the Ohio Medicaid MCE External Medical Review Request (PDF), which is available on Permedion. Providers need to upload the request form and all supporting documentation to the HMS eCenter (hmsy.com). If the provider is a new user, the provider can send documentation by secure email to imr@gainwelltechnologies.com to establish website access. Services denied for reasons other than lack of medical necessity are not subject to EMR. Examples include noncovered services and timely denials. Trainings available: If you have questions, contact your provider relationship account manager or send an email to ohiomedicaidprovider@anthem.com. View this map (PDF) to identify your provider relationship account manager. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-069267-24 A message from the Ohio Department of Medicaid The Ohio Department of Medicaid (ODM) resumed provider revalidations in June 2023. It is imperative that providers who are due for revalidation take immediate action, as terminations resumed January 23, 2024. All providers are subject to either three- or five-year, time-limited Provider Agreements. Letters are mailed and emailed 120 days, 90 days, and 60 days prior to termination, and a final notice is sent 30 days prior to termination. Providers who do not submit their revalidation could experience a termination at the state level — which would cascade to the managed care entities (MCEs) and cause claim denials as a non-participating provider. Emails will come from OHPNM@maximus.com. Revalidation notices are posted in the Provider Network Management (PNM) module and can be accessed in the Correspondence folder. Providers will also see a Begin Revalidation option in the PNM Enrollment Action Selection 120 days prior to the Medicaid Agreement end date. Providers can locate this under Manage Application > Enrollment Actions within the provider file. Refer to the Quick Reference Guide: Revalidation/Reenrollment (maximus.com) for step-by-step instructions. Providers who need technical assistance can contact ODM’s integrated help desk at 800-686-1516 and follow the prompts for provider enrollment, or providers can email IHD@medicaid.ohio.gov. To learn more about the PNM module and centralized credentialing, visit the PNM & Centralized Credentialing page (ohio.gov) on the Next Generation Program website (ohio.gov). Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-060523-24, OHBCBS-CD-060525-24, OHBCBS-CD-060526-24 Find Care, the doctor finder and transparency tool in the Anthem online directory, provides Anthem members with the ability to search for in-network providers using the secure member website. This tool currently offers multiple sorting options such as sorting providers based on distance, alphabetical order, and provider name. In our November 2022 newsletter, we provided an update regarding Personalized Match, an additional Find Care sorting option for Commercial members. We informed you that this provider sorting option was based on provider efficiency and quality outcomes described in a methodology document linked in the newsletter article, in addition to member search radius. We want to inform you that, beginning in December 2024 or later, we will be enhancing Personalized Match. This will expand upon the existing program. Newer components of the provider personalization metrics will contain up to 10 times as many features as compared to existing metrics such as gaps in care and additional types of service cost and utilization. Personalized Match will continue to display providers with the highest overall ranking within the member’s search radius, first. Members will continue to have the ability to sort based on distance, alphabetical order, and provider name. Helpful resources on AvailityYou may review a copy of the Personalized Match methodology that has been posted on Availity, our secure web-based provider tool, using the following navigation: - Go to Availity > Payer Spaces > Health Plan > Education & Reference Center > Administrative Support > Personalized Match Methodology.pdf.
If you have general questions regarding these upcoming changes, please submit an inquiry via the web at Availity.com. If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com. Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-061391-24, MULTI-BCBS-CM-070287-24 Summary: - The Personalized Match sorting option in the Find Care tool will be enhanced to provide more personalized care provider suggestions based on gaps in care and member history derived from clinical data, beginning December 2024.
- Members will be able to find details on the enhanced Personalized Match methodology in the online directory, and care providers will be able to submit inquiries or request reconsideration of care provider scores.
Find Care, the provider finder and transparency tool in the Anthem online directory, allows members to search for in-network care providers using the secure member website at anthem.com/find-care. This tool currently offers multiple sorting options, such as sorting providers based on Personalized Match, distance, alphabetic order, and care provider name. Beginning December 2024 or later, the Personalized Match sorting option will be enhanced for members. This sorting option currently considers care provider efficiency and quality outcomes. Enhancements will include gaps in care, such as HEDIS® measures and other market-specific clinical care measures, knowledge about member history derived from claims and other available clinical data, and member search radius. Care provider pairings with the highest overall ranking within the member’s search radius will be displayed first. Members will continue to be able to sort based on distance, alphabetic order, and care provider name: - You may review a copy of the Personalized Match methodology that has been posted on Availity Essentials — our secure web-based care provider tool — using the following navigation: Go to Availity.com > Payer Spaces > Select the Payer > Provider Online Reporting > Programs > Select a Program > Personalized Match > Personalized Match Methodology Phase 2 - Medicaid.pdf.
- If you have general questions regarding this new sorting option, please submit an inquiry to Availity.com.
- If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com.
Going forward, we will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-065652-24-CPN65561 Anthem has a continued mission to leverage digital technology to provide enhanced services for both members and care providers. We encourage the support of care providers in accepting digital ID cards instead of a physical member ID card. As members increasingly use digital ID cards, care providers may need to implement changes in their processes to accept this format. Due to recent enhancements, care providers can bypass the request for cards by accessing Availity.com. If a copy of a physical member identification card is needed, a member can email, fax, or access card details saved in their digital wallet. As a reminder, care providers can also access eligibility and benefit information without the health care identification (HCID). This makes both check-ins and submitting claims easier and faster. Anthem is dedicated to providing digital solutions that transform both care provider and payer interactions. Thank you in advance for your continued partnership and support in empowering our members to use their digital ID cards. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069066-24, MULTI-BCBS-CM-077976-25 We are in the process of shutting down specific authorization fax channels. This is to notify you that the fax numbers below will be decommissioned on November 15, 2024.
Look for additional notifications as other authorization fax lines are retired.
Availity Essentials is the preferred method for authorization intakes. If you cannot use Availity Essentials, call our contact center at 833-545-9102, and we will work with you to determine the best submission method.
Available resources
Registering and accessing Availity Essentials is easy. If your organization is not registered for Availity Essentials, see Register and get started with Availity Essentials (Availity.com).
If you are not already familiar with Availity Essentials, training is available. Register for training today. Under Help and Learning, select Get Trained and learn about the simple workflow for submitting digital authorizations.
These fax numbers will be turned off on November 15, 2024.
800-773-7797
|
800-266-3504
|
866-959-1393
|
877-254-4971
|
866-959-1395
|
404-467-2600
|
404-842-8390
|
404-848-2448
|
804-354-2578
|
804-354-3307
|
804-354-3882
|
804-678-0650
|
|
|
|
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070105-24 We are excited to announce the release of an Applied Behavior Analysis (ABA) Provider Resource Guide designed to assist with proper billing and documentation practices. This essential guide simplifies the complexities of ABA coding and requirements, ensuring that you can navigate these processes with ease. Refer to attached ABA Provider Resource Guide. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-072382-24-CPN72379 ATTACHMENTS (available on web): ABA Provider Resource Guide - Anthem Blue Cross Blue Shield (pdf - 0.39mb) As respiratory syncytial virus (RSV) season approaches, we would like to remind providers about available RSV immunizations to help prevent severe RSV related disease in infants. According to a report from the CDC (March 2024), infant preventive antibodies showed 90% effectiveness against the need for hospitalization for RSV in babies. Two immunizations are available to prevent RSV lower respiratory tract infections in infants: - Pfizer's Abrysvo, a maternal vaccine given during pregnancy
- Nirsevimab (Beyfortus), a monoclonal antibody administered to the baby
The maternal vaccine, Abrysvo, is recommended for those who are 32 to 36 weeks pregnant during RSV season, which generally falls between October and March. The vaccine can provide protection for infants up to six months if the mother receives it at least two weeks prior to delivery. Nirsevimab (Beyfortus) provides up to five months of protection against RSV and is approved for infants under 8 months during their first RSV season, and certain children between 8 and 19 months at increased risk of severe RSV disease. In some cases where a mother received an RSV vaccine, Nirsevimab can still be considered for the child if there is a substantial risk for severe RSV disease or if the maternal immune response to the vaccination is inadequate. Nirsevimab is covered under the Vaccines for Children Program. Additional information about RSV prevention and Nirsevimab (Beyfortus) can be found at cdc.gov/rsv. We look forward to sharing resources and working with you to achieve improved outcomes for children in our communities. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068150-24-CPN67753 As a contracted provider for a special needs plan (SNP) from Anthem, you are required to participate in an annual Model of Care training for providers, per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information, highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members, ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes. Training for the SNP product is self-paced and available at Availity.com. The training must be completed by December 31, 2024. How to access the Custom Learning Center:- Log in to the Availity website at Availity.com.
- At the top of the Availity website, select Payer Spaces and select the appropriate payer.
- On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
- In the Custom Learning Center, select Required Training.
- Select Special Needs Plan and Model of Care Overview.
- Select Enroll.
- Select Start.
- Once the course is completed, select Begin Attestation and complete.
Not registered for Availity Essentials?Have your organization’s designated administrator register your organization for the Availity website: - Visit Availity.com to register.
- Select Register.
- Select your organization type.
- In the Registration wizard, follow the prompts to complete the registration for your organization.
Refer to these PDF documents for complete registration instructions. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-070560-24-CPN70218 Anthem invites our Medicaid care providers in Ohio to participate in our Provider Advisory Council. The meeting’s intent is to collaborate with our provider community and gather input, discuss trends, identify challenges, and remove barriers — ultimately improving the healthcare delivery system. If you are interested in participating, sign up by visiting the link below. Provider Advisory Council sign-up (chkmkt.com) Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-059838-24, OHBCBS-CD-059843-24, OHBCBS-CD-059847-24 All hospice providers are invited to attend a hospice education webinar. The Ohio Medicaid Provider Relationship Account Management team webinar will provide education on Anthem’s billing guidelines. If you have any questions, please email ohmedicaidencpesupport@elevancehealth.com. Through genuine collaboration, we can help solve real needs in a sustainable way. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068025-24 Our Provider Relationship Management team will host our next behavioral health provider orientation on November 13th, 2024, at 9 a.m. ET. Please join us to learn more about working with us and supporting your patients and our members. If you have questions, please contact your provider relationship manager or email OhioMedicaidProvider@anthem.com. Through genuine collaboration, we can work to achieve improved outcomes in patients’ health. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068023-24 Orientation happening soonThe Ohio Medicaid Provider Relationship Account Management team will be hosting our next provider orientation in November. The orientation will cover everything you need to know to work with Anthem members enrolled in Medicaid in Ohio. 
| Monday, November 18, 2024 | 1 p.m. ETVirtual presentation |
RegisterVisit https://us.mar.medallia.com/?e=412439&d=l&h=87C2D15D588CFE7&l=en We’re here to answer any questionsIf you have questions, contact your provider relationship account manager or email ohiomedicaidprovider@anthem.com. Through genuine collaboration, we can work to achieve improved outcomes in patients’ health. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068021-24 In the July 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care, effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here. Site of Care Guidelines: - Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-067576-24-CPN67268 Effective November 17, 2024 This article was updated on November 24, 2024 to change the effective date from October 26, 2024 to November 17, 2024. Effective on November 17, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here: - Musculoskeletal:
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-065139-24-CPN64434, MULTI-ALL-CR-074348-24 Effective November 30, 2024 Effective on November 30, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement for these services will be implemented, a separate notice will be distributed before the addition of any prior authorization requirements. You may access and download a copy of the current and upcoming guidelines here. The above guideline updates have a publish date of April 14, 2024. - Cardiology:
- Genetic Testing:
- Pharmacogenomic Testing
- Predictive and Prognostic Polygenic Testing
- Chromosomal Microarray Analysis
- Whole Exome Sequencing and Whole Genome Sequencing
- Somatic Tumor Testing
- Musculoskeletal:
- Spine Surgery
- Sacroiliac Joint Fusion
- Radiology:
- Vascular Imaging
- Imaging of the Brain
The above guideline updates have a publish date of October 20, 2024. - Genetic Testing:
- Cell-free DNA Testing for the Management of Cancer
- Prenatal Testing using cell-free DNA
- Somatic Tumor Testing
- Musculoskeletal:
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other providers in your practice and office staff. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068454-24 Effective December 1, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note that several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Medical Policies and Clinical UM Guidelines. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive: - MED.00148 - Gene Therapy for Metachromatic Leukodystrophy:
- Outlines the Medically Necessary and Not Medically Necessary criteria for gene therapy for metachromatic leukodystrophy
Medical PoliciesOn May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect December 1, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 5/16/2024 | *MED.00148 | Gene Therapy for Metachromatic Leukodystrophy | Revised | 6/28/2024 | ADMIN.00007 | Immunizations | Reviewed | 6/28/2024 | MED.00013 | Parenteral Antibiotics for the Treatment of Lyme Disease | Revised |
Clinical UM GuidelinesOn May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on June 27, 2024. These guidelines take effect December 1, 2024. Publish Date | Clinical UM Guideline Number | Clinical UM Guideline Title | New or Revised | 6/28/2024 | CG-DME-55 | Automated External Defibrillators for Home Use | New | 6/28/2024 | CG-MED-90 | Chelation Therapy | Reviewed |
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-069582-24 Effective November 30, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Four, 2023. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit https://providers.anthem.com/ohio-provider/resources/manuals-and-guides. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive. Medical PoliciesOn November 9, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect November 30, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 1/3/2024 | MED.00128 | Insulin Potentiation Therapy | Reviewed |
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068457-24 Effective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization is required if the request is for gender-affirming care services, including but not limited to diagnoses codes F64.0, F64.1, F64.2, F64.8, F64.9, or Z87.890. Ohio law prohibits Medicaid coverage of inpatient and outpatient hospital services relating to gender transformation. Code | Description | 11401 | Excise, Benign Skin Lesion, Incl Margins, Except Skin Tag, Trunk/Arms/Legs; Excised Diam 0.6-1.0 Cm | 11406 | Excise, Benign Skin Lesion, Incl Margins, Except Skin Tag, Trunk/Arms/Legs; Excised Diam > 4.0 Cm | 11420 | Excise Benign Skin Lesion W/Marg, Excpt Skin Tag Scalp/Neck/Hands/Feet/Genital; Excise Diam 0.5cm/< | 12031 | Repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet); 2.5 cm or less | 13121 | Repair, Complex, Scalp, Arms, &/Or Legs; 2.6 To 7.5 Cm | 13122 | Repair, Complex, Scalp/Arms/Legs; Add'l 5.0 Cm/< | 14060 | Adjacent Tissue Transfer/Rearrangement, Eyelids/Nose/Ears/Lips; Defect 10 Sq Cm/< | 15002 | Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar (including subcutaneous tissues), or incisional release of scar contracture, trunk, arms, legs; first 100 sq cm or 1% of body area of infants and children | 15115 | Epidermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children | 15150 | Tissue cultured skin autograft, trunk, arms, legs; first 25 sq cm or less | 15151 | Tissue cultured skin autograft, trunk, arms, legs; additional 1 sq cm to 75 sq cm (List separately in addition to code for primary procedure) | 15155 | Tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 25 sq cm or less | 15156 | Epidermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children | 15770 | Graft; Derma-Fat-Fascia | 20902 | Bone graft, any donor area; major or large | 20912 | Cartilage graft; nasal septum | 21085 | Impression & Custom Preparation; Oral Surgical Splint | 21555 | Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm | 31579 | Laryngoscopy, flexible or rigid telescopic, with stroboscopy | 51610 | Injection Proc, Retrograde Urethrocystography | 51703 | Insertion, Temporary Indwelling Bladder Catheter; Complicated | 52000 | Cystourethroscopy (Sep Proc) | 52281 | Cystourethroscopy, W/Calibration &/Or Dilation, Urethral Stricture/Stenosis, Male/Female | 53010 | Urethrotomy/Urethrostomy, Ext (Sep Proc); Perineal Urethra, Ext | 53400 | Urethroplasty; 1st Stage, Fistula/Diverticulum/Stricture | 53405 | Urethroplasty; 2nd Stage (Formation, Urethra), W/Urinary Diversion | 55120 | Removal, Fb In Scrotum | 64874 | Suture, Nerve; W/Extensive Mobilization/Transposition, Nerve | 67901 | Repair of blepharoptosis; frontalis muscle technique with suture or other material (eg, banked fascia) | 67903 | Repair, Blepharoptosis; (Tarso) Levator Resection/Advancement, Int Approach | 67904 | Repair, Blepharoptosis; (Tarso) Levator Resection/Advancement, Ext Approach | 67906 | Repair, Blepharoptosis; Superior Rectus W/Fascial Sling | 67908 | Repair, Blepharoptosis; Conjunctivo-Tarso-Muller's Muscle-Levator Resection | 67923 | Repair, Entropion; Blepharoplasty, Excision Tarsal Wedge | 67924 | Repair, Entropion; Blepharoplasty, Extensive | 97606 | Negative Pressure Wound Therapy, Per Session; Total Area > 50 Sq Cm | 99205 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded. | C5272 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) | C5274 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) | C5276 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) | C5277 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children | C5278 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) | Q4116 | Alloderm, per square centimeter | Q4176 | Neopatch or Therion, per sq cm |
To request PA, you may use one of the following methods: - Web: once logged in to Availity Essentials at Availity.com
- Fax:
- 877-643-0672 for Physical Health
- 866-577-2183 for Behavioral Health
- Phone: 800-601-9935
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://providers.anthem.com/oh on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 844-912-1226 for assistance with PA requirements. UM AROW A2024M2246 Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-069058-24-CPN68578 Effective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicaid and CHIP members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0141U | Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected | 0142U | Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected | 0321U | Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique | 0449T | Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device | 21086 | Impression & Custom Preparation; Auricular Prosthesis | 36468 | Injection(s) of sclerosant for spider veins (telangiectasia), limb or trunk | 36473 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated | 37241 | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (for example, congenital or acquired venous malformations, venous and capillary hemangiomas, varices, varicoceles) | 61885 | Subq Placement Cranial Neurostimulator Pulse Generator/Receiver; W/Connection Sngle Electrod Array | 64568 | Open implantation of cranial nerve (for example, vagus nerve) neurostimulator electrode array and pulse generator | 64569 | Revision or replacement of cranial nerve (for example, vagus nerve) neurostimulator electrode array, including connection to existing pulse generator | 66183 | Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach | 66989 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (for example, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with insertion of intraocular (for example, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 66991 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification); with insertion of intraocular (for example,, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 82107 | Alpha-fetoprotein (AFP); AFP-L3 fraction isoform and total AFP (including ratio) | 86304 | Immunoassay, Tumor Antigen, Quantitative; Ca 125 | 95976 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with simple cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 95977 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with complex cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 97760 | Orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes | 97763 | Orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes | A2026 | Restrata MiniMatrix, 5 mg | A4438 | Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each | C1734 | Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) | C9796 | Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (for example, porcine small intestine submucosa [SIS]) | C9797 | Vascular embolization or occlusion procedure with use of a pressure-generating catheter (for example, one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction | E0735 | Non-invasive vagus nerve stimulator | E2298 | Complex rehabilitative power wheelchair accessory, power seat elevation system, any type | Q4305 | American Amnion AC Tri-Layer, per sq cm | Q4306 | American Amnion AC, per sq cm | Q4307 | American Amnion, per sq cm | Q4308 | Sanopellis, per sq cm | Q4309 | VIA Matrix, per sq cm | Q4310 | Procenta, per 100 mg |
To request PA, you may use one of the following methods:
- Web: Log in to Availity.com.
- Fax: 877-643-0672 — physical health, 866-577-2183 — behavioral health
- Phone: 800-601-9935
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://providers.anthem.com/oh on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 844-912-1226 for assistance with PA requirements. UM AROW #: A2024M187 Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-065605-24-CPN65118 Effective February 1, 2025 Effective February 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non‑compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 0456U | Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy PrismRA®, Scipher Medicine®, Scipher Medicine® | 0459U | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology Elecsys® Total Tau CSF (tTau) and β-Amyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator) | 0468U | Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis NASHnext™ (NIS4™), Labcorp, Labcorp | J0687 | Injection, cefazolin sodium (WG Critical Care), not therapeutically equivalent to J0690, 500 mg | J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | J2183 | Injection, meropenem (WG Critical Care), not therapeutically equivalent to J2185, 100 mg | J2184 | Injection, meropenem (B. Braun), not therapeutically equivalent to J2185, 100 mg | J2281 | Injection, moxifloxacin (Fresenius Kabi), not therapeutically equivalent to J2280, 100 mg |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at the number on the back of the patient’s member ID card for assistance with PA requirements. UM AROW #: A2024M2186 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-068215-24-CPN67511 Reimbursement Policies | Commercial | November 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Reimbursement policy update: Nurse Practitioner and Physician Assistant ServicesBeginning with dates of service on or after February 1, 2025, Anthem will update the Nurse Practitioner and Physician Assistant Services — Professional reimbursement policy as indicated below. The following services will be removed from the policy and are eligible for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider: - Preventive Services
- Radiology Services
The following services will be added to the policy and will not be considered for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider: - Drugs
- Durable Medical Equipment, Prosthetics, Orthotics and Supplies
- Laboratory Services and Laboratory Screening Tests
For specific policy details, visit the reimbursement policy page by selecting here. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069779-24 As a reminder, and as previously communicated through letters we mailed to participating facilities on October 1, 2021, we allow reimbursement for only the primary or highest-valued procedure when multiple or bilateral procedures are performed on the same day or same session and at the same place of treatment when billed by a facility. A single surgical procedure is subject to multiple procedure reduction guidelines when submitted with multiple units. For specific Multiple Surgery — Facility reimbursement policy details, visit the reimbursement policy page. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-068278-24-CPN68051 At a glance: - High Performing Providers will also be known as Anthem Diamond Providers.
- Providers receiving a designation based on the Blue National Physician Performance Dataset will also be known as Anthem Diamond Providers (National).
High Performing Provider programOver the last several months, we have communicated with our providers about our High Performing Provider program. PCPs and specialists meeting certain criteria are designated High Performing Providers. High Performing Providers may also be referred to as Anthem Diamond Providers. As a reminder, the following specialties may be designated High Performing Providers (aka Anthem Diamond Providers) from this program: - PCP: family practice, general practice, geriatric medicine, internal medicine, pediatric medicine, and nurse practitioners
- Specialists: cardiology, endocrinology, nephrology, neurology, neurosurgery, obstetrics gynecology, orthopedic surgery, psychiatry, pulmonology, and rheumatology
If you have any questions about this program, contact Provider Services or your local provider relationship management representative. Blue National Physician Performance DatasetThis is an Anthem designation program for providers in networks supporting Anthem national accounts and certain out-of-area providers. As we previously communicated to you, effective January 1, 2025, Anthem may incorporate insights from the Blue National Physician Performance Dataset (Dataset) in various initiatives. For Anthem national accounts and certain out-of-area providers, Anthem will use data made available in the Dataset to assess individual physician’s performance at the NPI level. The individual physician’s performance is assessed across the three domains — cost of care/efficiency, quality of care, and appropriateness of care — for the following 16 primary care and specialty areas: cardiothoracic surgery, cardiovascular disease, endocrinology, neurology, ob/gyn, ophthalmology, orthopedics, pediatrics, primary care, pulmonology, surgery, urology, gastroenterology, otolaryngology, oncology, and radiation oncology. The providers who qualify for the designation from this Dataset program will also be referred to as Anthem Diamond Providers (National). If you have any questions regarding this, contact your local provider relationship management representative. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070326-24 Our digital-first initiative allows you to submit EDI-corrected claims using the Availity Essentials website or through electronic data interchange (EDI). The corrected claims process begins when a claim has already been adjudicated. Multiple types of errors that occur can typically be corrected quickly with the options below. Availity Essentials corrected claim submissionIf we have already accepted the original claim for processing, you can recreate it and submit it as a corrected replacement or cancellation (void) of the original claim. Follow these steps:- In the Availity Essentials menu, select Claims & Payments and then select Professional Claim or Facility Claim, depending on which type of claim you want to correct:
- Enter the claim information, and set the billing frequency and payer control number as follows:
- Replacement of Prior Claim or Void/Cancel of Prior Claim
- Billing Frequency (or Frequency Type) field in the Claim Information section (for professional and facility claims) or Ancillary Claim/Treatment Information section (for dental claims)
- Ensure all lines are submitted on the claim
- Note: The original claim processed will be voided, and the new corrected and/or replacement claim will be processed.
- Set the Payer Control Number (ICN / DCN) (or Payer Claim Control Number) field to the claim number we assigned to the claim. You can obtain this number from the 835 ERA or Remittance Inquiry on Payer Spaces.
- Submit the claim.
EDI corrected claim submissionCorrected claims submitted electronically must also have the applicable frequency code. The frequency code indicates the claim is a correction of a previously submitted and adjudicated claim. Providers should use one of the following: - For corrected professional (837P) claims, use one of the following frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 6 — Corrected Claim of Prior Claim
- 7 — Replacement of Prior Claim
- 8 — Void/Cancel Prior Claim
Note: When a replacement or corrected claim (0XX7 or 0XX6) is submitted, the original claim will be voided, and the new or corrected claim will be processed: - For corrected institutional (837I) claims, use bill type frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 0XX6 — Corrected Claim of Prior Claim
- 0XX7 — Replacement of Prior Claim
- 0XX8 — Void/Cancel Prior Claim
Please check with your practice management software vendor, billing service, or clearinghouse for the full details of submitting corrected claims. We encourage you and your staff to use the digital methods available to submit corrected claims to save costs in mailing, paper, and your valuable time. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-068980-24 Pharmacy | Commercial | July 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Correction: Specialty pharmacy updates — July 2024This article was updated on October 9, 2024, to remove Ilumya as non-preferred from the step therapy requirements section below. Ilumya is not being added to the step therapy program at this time. Specialty pharmacy updates for Anthem are listed below. Anthem’s medical specialty drug review team manages prior authorization (PA) clinical review of non-oncology use of specialty pharmacy drugs. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request PA review for your patients’ continued use of these medications. Inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our PA review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® Code(s) | CC-0003* | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: PA requests for certain medications may require additional documentation to determine medical necessity. Step therapy updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT Code(s) | CC-0003 | Non-preferred | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Non-preferred | Cimzia (certolizumab pegol) | J0717 | CC-0042 | Non-preferred | Cosentyx intravenous (secukinumab) | C9399, J3490, J3590, C9166 | CC-0050 | Non-preferred | Omvoh (mirkizumab-mrkz) | C9168, J3590 |
Quantity limit updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT Code(s) | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-060687-24-CPN60563, MULTI-BCBS-CM-069897-24 Pharmacy | Commercial | October 24, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Specialty pharmacy updates — November 2024Specialty pharmacy updates for Anthem are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Inclusion of the national drug code (NDC) on your claim will help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. Prior authorization updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0027* | Jubbonti; Wyost (denosumab-bbdz) | Q5136 | CC-0002* | Nypozi (filgrastim-txid) | C9399, J3590 | CC-0266* | Rytelo (imetelstat) | C9399, J9999 | CC-0003* | Yimmugo (immune globulin intravenous, human–dira) | J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Step therapy updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. The current Orencia step therapy preferred product list under the medical benefit is being modified to include only those that are considered medical benefit drugs. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT code(s) | CC-0002 | Non-preferred | Nypozi | C9399, J3590 | CC-0003 | Non-preferred | Yimmugo | J3590 |
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Site of care updatesEffective for dates of service on and after February 1, 2025, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our site of care review process. Access our Clinical Criteria to view the complete information for these site of care updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0003 | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0066 | Tyenne (tocilizumab-aazg) | Q5135 |
Quantity limit updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0266 | Rytelo (imetelstat) | C9399, J9999 | CC-0027 | Jubbonti; Wyost (denosumab-bbdz) | Q5136 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069728-24-CPN69536 Enhanced adherence mitigates healthcare costs and improves patient outcomes and quality of life. Promoting medication adherence and advocating for statin use among diabetes patients is critical. Statin use in diabetes:- Diabetics are two to four times more likely to die from heart disease (American Heart Association).
- Statins lower LDL cholesterol, reducing cardiovascular events by 25 to 60%.
- Statin use is low, particularly in younger, female, and black individuals.
- Delayed statin use increases cardiovascular disease risk in diabetic patients.
- National guidelines recommend statin therapy for diabetics ages 40 to 75, regardless of LDL levels.
- CMS has adopted the Statin Use in Persons with Diabetes (SUPD) measure to combat cardiovascular death in diabetic patients.
Medication adherence:- Poor adherence increases morbidity and mortality, causing more than 125,000 deaths and 10% of hospitalizations annually in the United States.
- Forty-five percent of U.S. adults have hypertension and only 24% manage it effectively, largely due to non-adherence.
- High adherence in diabetic patients reduces hospitalization risks by 30%.
- Improved adherence can save $1,200 to $8,000 per patient annually.
Supporting patients:- Simplify the regimen: Prescribe medications with fewer daily doses.
- Regular follow-ups: Ensure correct medication use and adjust doses as needed.
- Clear communication: Explain medication benefits, risks of non-compliance, and side effects.
- Extended prescriptions: Provide 90 to 100 days’ supply and sufficient refills.
- Home delivery: Eliminate transportation barriers.
- Address statin hesitancy: Discuss pros and cons and involve family in decisions.
- Use technology: Set up reminders through mobile apps, SMS, email, or pill containers.
- Address cost issues: Prescribe affordable options and explore assistance programs.
- Personalized care: Tailor medication plans to the patient's lifestyle and needs.
References: - American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
- Bradley CK, Wang TY, Li S, et al. Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
- Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. doi: http://dx.doi.org/10.15585/mmwr.mm6735a4
- 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
- CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. https://www.cdc.gov/diabetes/library/features/Statins_Diabetes.html
- Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
- Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/S0140-6736(16)31357-5
- Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. https://www.acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
- Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680
- Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. 5 June 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed 16 May 2023
- Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023. https://www.ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications
- El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022;106(4):615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-069868-24-CPN69806 At a glance:- Care providers must prepare for HEDIS® medical record reviews starting January 2025.
- Care providers will submit records through Remote Electronic Medical Record (EMR) Access Service, website upload, fax, secure file transfer protocol (SFTP), mail, or on-site.
BackgroundEach year, we perform a review of a sample of our members’ medical records as part of the HEDIS quality study. HEDIS is part of a nationally recognized quality improvement initiative and is used by the Centers for Medicare & Medicaid Services (CMS), the National Committee for Quality Assurance (NCQA), and several states to monitor the performance of managed care organizations. We will begin requesting medical records in January 2025. No special authorization is needed for you to share member medical record information with us since quality assessment and improvement activities are routine parts of healthcare operations. Ways to submit your records in our preferred order:- Remote EMR Access Service: We offer the Remote EMR Access Service to care providers to submit member medical record information to us. If you are interested in more information, contact us at Centralized_EMR_Team@anthem.com.
- Upload: Medical records can be uploaded to our secure website using the instructions in the request document.
- Fax: Medical records can be faxed to us using the instructions in the request document.
- SFTP: Medical records can be uploaded via a secure website.
- U. S. Postal Service: Medical records can be mailed to us using the instructions in the request document.
- On-site: Medical records can be pulled by a representative at your local office where medical records are located.
HEDIS review is time sensitive, so submit the requested medical records within the timeframe indicated in the initial HEDIS request document. We appreciate the care you provide our members. Your assistance is crucial to ensuring our data is statistically valid, auditable, and accurately reflects quality performance. Contact usAvaility Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat. For additional support, visit the Contact Us section of our provider website for the appropriate contact. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Anthem Blue Cross and Blue Shield and Anthem Blue Cross and Blue Shield Medicaid are trade names of Community Insurance Company. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CDCRCM-069949-24-CPN69632, OHBCBS-CDCRCM-071181-24-CPN71157 The Consumer Assessment of Healthcare Providers and Systems® (CAHPS) is an annual standardized survey conducted anonymously by a third-party vendor (Center for the Study of Services) to assess a random sample of consumers' experiences with their health plan, their personal provider, and healthcare services. Refer to attachment to view full details. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-068379-24-CPN67980 ATTACHMENTS (available on web): Provider: CAHPS awareness (pdf - 0.08mb) |